Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris
American Journal of Infection Control · 2023
DOI: 10.1016/j.ajic.2023.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Infection Control, 2023. Verfasst von David J Weber und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC; Department of Infection Prevention, UNC Medical C…. Hauptthemen laut MEDLINE: Communicable Diseases, Emerging, Mpox, Monkeypox, COVID-19, Disinfectants. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 224 Literaturangaben.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
BACKGROUND: New and emerging infectious diseases continue to represent a public health threat. Emerging infectious disease threats include pathogens increasing in range (eg, Mpox), zoonotic microbes jumping species lines to cause sustained infections in humans via person-to-person transmission (SARS-CoV-2) and multidrug-resistant pathogens (eg, Candida auris). MATERIALS AND METHODS: We searched the published English literature and reviewed the selected articles on SARS-CoV-2, Mpox, and Candida auris with a focus on environmental survival, contamination of the patient's hospital environment, susceptibility of the pathogen to antiseptics and disinfectants and infection prevention recommendations. RESULTS: All three pathogens (ie, SARS-CoV-2, Mpox, and Candida auris) can survive on surfaces for minutes to hours and for Mpox and C auris for days. Currently available antiseptics (eg, 70%-90% alcohol hand hygiene products) are active against SARS-CoV-2, Mpox and C auris. The U.S Environmental Protection Agency provides separate lists of surface disinfectants active against SARS-CoV-2, Mpox, and C auris. DISCUSSION: The risk of environment-to-patient transmission of SARS-CoV-2, Mpox and Candida auris, is very low, low-moderate and high, respectively. In the absence of appropriate patient isolation and use of personal protection equipment, the risk of patient-to-health care provider transmission of SARS-CoV-2, Mpox, and C auris is high, moderate and low, respectively. CONCLUSIONS: Appropriate patient isolation, use of personal protective equipment by health care personnel, hand hygiene, and surface disinfection can protect patients and health care personnel from acquiring SARS-CoV-2, Mpox, and C auris from infected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC; Department of Infection Prevention, UNC Medical Center, Chapel Hill, NC; Department of Epidemiology, Gillings School of…
- Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC.
Zitieren
APA
Weber, D. J., Rutala, W. A., & Sickbert-Bennett, E. (2023). Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris. American Journal of Infection Control. https://doi.org/10.1016/j.ajic.2023.02.006
Vancouver
Weber DJ, Rutala WA, Sickbert-Bennett E. Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris. American Journal of Infection Control. 2023. doi:10.1016/j.ajic.2023.02.006
BibTeX
@article{Weber2023,
author = {Weber, David J and Rutala, William A and Sickbert-Bennett, Emily},
title = {Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris},
journal = {American Journal of Infection Control},
year = {2023},
doi = {10.1016/j.ajic.2023.02.006}
}
EUVIMED